Free Trial
NASDAQ:AADI

Aadi Bioscience (AADI) Stock Price, News & Analysis

Aadi Bioscience logo
$2.01 +0.02 (+1.01%)
As of 07/9/2025

About Aadi Bioscience Stock (NASDAQ:AADI)

Key Stats

Today's Range
$1.99
$2.06
50-Day Range
$1.58
$2.09
52-Week Range
$1.21
$3.81
Volume
278,993 shs
Average Volume
254,575 shs
Market Capitalization
$49.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.67
Consensus Rating
Hold

Company Overview

Aadi Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

AADI MarketRank™: 

Aadi Bioscience scored higher than 12% of companies evaluated by MarketBeat, and ranked 879th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aadi Bioscience has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aadi Bioscience has received no research coverage in the past 90 days.

  • Read more about Aadi Bioscience's stock forecast and price target.
  • Earnings Growth

    Earnings for Aadi Bioscience are expected to grow in the coming year, from ($2.04) to ($0.94) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aadi Bioscience is -0.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aadi Bioscience is -0.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aadi Bioscience has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aadi Bioscience's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AADI.
  • Dividend Yield

    Aadi Bioscience does not currently pay a dividend.

  • Dividend Growth

    Aadi Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AADI.
  • Search Interest

    3 people have searched for AADI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aadi Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    37.30% of the stock of Aadi Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.08% of the stock of Aadi Bioscience is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aadi Bioscience's insider trading history.
Receive AADI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter.

AADI Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

AADI Stock Analysis - Frequently Asked Questions

Aadi Bioscience's stock was trading at $3.15 on January 1st, 2025. Since then, AADI shares have decreased by 36.2% and is now trading at $2.01.

Aadi Bioscience, Inc. (NASDAQ:AADI) posted its quarterly earnings results on Tuesday, March, 18th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.37. The business earned $7.24 million during the quarter, compared to analysts' expectations of $7.45 million. Aadi Bioscience had a negative net margin of 246.06% and a negative trailing twelve-month return on equity of 71.87%.
Read the conference call transcript
.

Aadi Bioscience shares reverse split on the morning of Friday, August 27th 2021.The 1-15 reverse split was announced on Thursday, August 26th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 25th 2021. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of AADI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aadi Bioscience investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Moderna (MRNA), NVIDIA (NVDA) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/18/2025
Today
7/10/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AADI
CIK
1422142
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$1.75
Low Price Target
$1.50
Potential Upside/Downside
-17.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.76 million
Net Margins
-246.06%
Pretax Margin
-246.06%
Return on Equity
-71.87%
Return on Assets
-57.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.89
Quick Ratio
4.54

Sales & Book Value

Annual Sales
$25.07 million
Price / Sales
1.98
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.29 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
24,697,000
Free Float
15,485,000
Market Cap
$49.64 million
Optionable
Optionable
Beta
0.68
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:AADI) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners